← Back to Case Studies

Helping launch a product that treats epilepsy seizures.

Epilepsy affects more than 3 million people in the US, resulting in possible shortened lifespan and impacting overall quality of life. Recently, Mavens worked with a leading biopharma company to prepare for the launch of a new product for the potential treatment of partial-onset seizures, improving patients’ lives.

Commercial

Challenge

The client needed help implementing Veeva CRM.

The client was scaling rapidly with a lean staff. They needed a partner with in-depth experience deploying Veeva CRM in a start-up pre-commercial environment. Mavens was engaged to enable effective field force deployment across the United States market and support the launch of a new product to the Central Nervous System health market.

Solution

Mavens leveraged our deep pre-commercial and Veeva experience.

Because the client was pre-commercial and had not hired the field force, we took a multi-phase approach to the project. The first phase focused on establishing Veeva CRM, configured to support the pre-launch needs for data visibility. This allowed the regional sales directors to prep for onboarding the field force. Subsequent phases will include additional enhancements based on field force needs as they ramp up, as well as integrations to a major data provider.

Subsequent phases will include additional enhancements based on field force needs as they ramp up, as well as integrations to a major data provider.

Results

The project rolled out on time and under budget.

By providing best-practice advisory on functionality based on the client’s needs, Mavens was able to expedite the client’s ability to make key decisions and keep the project on track. Within 14 weeks, the client was online with a CRM and trained so sales leadership could immediately begin working with the customer base.

By implementing the CRM as one of the first systems, Mavens provided the basis for building out a full view of sales-related data. The CRM was one of the first crucial pieces to set them on their path, preparing them to hit the ground running once they have FDA approval. Mavens was proud to help them on that journey.